glp-1 compound tirzepatide Oral 1 and GIP therapy Tirzepatide Subscription - Joi +

Those who continued tirzepatide maintained their weight loss and even experienced modest additional reductions

Ttirzepatide, a groundbreaking treatment developed by Eli Lilly and Company, has demonstrated significant efficacy in chronic weight management, particularly in the context of a comprehensive weight control center

Key Takeaways While tirzepatide is excellent at maintaining appetite and metabolic health to support weight loss, loose skin can be a side effect of such drastic changes

The key is to stick to the healthy habits developed during your treatment

Semaglutides weekly max dose is 2.4 mg , while Tirzepatide goes up to 15 mg